Griseofulvin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00400 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 22 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | myiasis | KG + DL |
| 2 | wound myiasis | KG + DL |
| 3 | furuncular myiasis | KG + DL |
| 4 | creeping myiasis | KG + DL |
| 5 | echinococcus granulosus infectious disease | KG + DL |
| 6 | cutaneous candidiasis | KG + DL |
| 7 | toxoplasmosis | KG + DL |
| 8 | alveolar echinococcosis | KG + DL |
| 9 | blastomycosis | KG + DL |
| 10 | Bacteroidaceae infectious disease | KG + DL |
| 11 | skin disease caused by infection | KG + DL |
| 12 | superficial mycosis | KG + DL |
| 13 | endothrix infectious disease | KG + DL |
| 14 | ophthalmic herpes zoster | KG + DL |
| 15 | infectious mononucleosis | KG + DL |
| 16 | ancylostomiasis | KG + DL |
| 17 | orbital cellulitis | KG + DL |
| 18 | ectothrix infectious disease | KG + DL |
| 19 | Majocchi granuloma | KG + DL |
| 20 | anaerobic bacteria infectious disease | KG + DL |
| 21 | pneumocystosis | KG + DL |
| 22 | tinea manuum | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.